Chung BH - Search Results

1

Persistence with solifenacin add-on therapy in men with benign prostate obstruction and residual symptoms of overactive bladder after tamsulosin monotherapy.

Lee YS, Lee KS, Kim JC, Hong S, Chung BH, Kim CS, Lee JG, Kim DK, Park CH, Park JK. Lee YS, et al. Among authors: chung bh. Int J Clin Pract. 2014 Dec;68(12):1496-502. doi: 10.1111/ijcp.12483. Epub 2014 Oct 6. Int J Clin Pract. 2014. PMID: 25284747

2

A PCR-RFLP method for the detection of activated H-ras oncogene with a point mutation at codon 12 and 61.

Hong SJ, Lee T, Park YS, Lee KO, Chung BH, Lee SH. Hong SJ, et al. Among authors: chung bh. Yonsei Med J. 1996 Dec;37(6):371-9. doi: 10.3349/ymj.1996.37.6.371. Yonsei Med J. 1996. PMID: 9048488 Free article.

3

Telomerase activity: a potential marker of bladder transitional cell carcinoma in bladder washes.

Yang SC, Lee DH, Hong SJ, Chung BH, Kim IY. Yang SC, et al. Among authors: chung bh. Yonsei Med J. 1997 Jun;38(3):155-9. doi: 10.3349/ymj.1997.38.3.155. Yonsei Med J. 1997. PMID: 9259615 Free article.

4

Telomerase: a potential marker of bladder transitional cell carcinoma in bladder washes.

Lee DH, Yang SC, Hong SJ, Chung BH, Kim IY. Lee DH, et al. Among authors: chung bh. Clin Cancer Res. 1998 Mar;4(3):535-8. Clin Cancer Res. 1998. PMID: 9533519

5

Identification of baseline clinical factors which predict medical treatment failure of benign prostatic hyperplasia: an observational cohort study.

Hong SJ, Ko WJ, Kim SI, Chung BH. Hong SJ, et al. Among authors: chung bh. Eur Urol. 2003 Jul;44(1):94-9; discussion 99-100. doi: 10.1016/s0302-2838(03)00199-4. Eur Urol. 2003. PMID: 12814681

6

Can a 12 core prostate biopsy increase the detection rate of prostate cancer versus 6 core?: a prospective randomized study in Korea.

Kim JW, Lee HY, Hong SJ, Chung BH. Kim JW, et al. Among authors: chung bh. Yonsei Med J. 2004 Aug 31;45(4):671-5. doi: 10.3349/ymj.2004.45.4.671. Yonsei Med J. 2004. PMID: 15344209 Free article. Clinical Trial.

7

Proper cut-off value of free to total PSA ratio for detection of prostate cancer in Korean men.

Im YJ, Kim JW, Hong SJ, Chung BH. Im YJ, et al. Among authors: chung bh. Yonsei Med J. 2004 Oct 31;45(5):873-8. doi: 10.3349/ymj.2004.45.5.873. Yonsei Med J. 2004. PMID: 15515198 Free article.

8

Doxazosin for benign prostatic hyperplasia: an open-label, baseline-controlled study in Korean general practice.

Chung BH, Hong SJ, Lee MS. Chung BH, et al. Int J Urol. 2005 Feb;12(2):159-65. doi: 10.1111/j.1442-2042.2005.00998.x. Int J Urol. 2005. PMID: 15733110 Clinical Trial.

9

Long-term follow-up study to evaluate the efficacy and safety of the doxazosin gastrointestinal therapeutic system in patients with benign prostatic hyperplasia with or without concomitant hypertension.

Chung BH, Hong SJ. Chung BH, et al. BJU Int. 2006 Jan;97(1):90-5. doi: 10.1111/j.1464-410X.2006.05858.x. BJU Int. 2006. PMID: 16336335

10

Detection rate of prostate cancer on biopsy according to serum prostate-specific antigen in Korean men: a multicenter study.

Yang WJ, Lee DH, Chung BH, Cho JS, Choi YD, Kim SJ, Cho IR, Kim HS, Kim CI, Hong SJ; Members of the Severance Urologic Oncology Group. Yang WJ, et al. Among authors: chung bh. Urology. 2006 Feb;67(2):333-6. doi: 10.1016/j.urology.2005.08.027. Urology. 2006. PMID: 16461083

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

994 results

Search Page

Filters